Strengthening the U.S. Biomedical Research Enterprise Entails National Strategic Coordination, Focus on Health Equity
| | | | | | | | | |

Strengthening the U.S. Biomedical Research Enterprise Entails National Strategic Coordination, Focus on Health Equity

On Oct. 1, 2024, the National Academy of Medicine (NAM) announced a study showing that although the U.S….

Superbugs could jeopardise food security for over two billion people and increase annual health care costs by U.S. $159 billion annually by 2050, finds most extensive modelling to date 
| | | |

Superbugs could jeopardise food security for over two billion people and increase annual health care costs by U.S. $159 billion annually by 2050, finds most extensive modelling to date 

On Sept. 25, 2024, drug-resistant pathogens could jeopardise the food supply of over two billion people and increase…

Air pollution, high temperatures, and metabolic risk factors driving global increases in stroke, with latest figures estimating 12 million cases and over 7 million deaths from stroke each year
| | | | | | |

Air pollution, high temperatures, and metabolic risk factors driving global increases in stroke, with latest figures estimating 12 million cases and over 7 million deaths from stroke each year

On Sept. 18, 2024, a study published in The Lancel reported that here has been a rapid rise…

FDA Approves Ocrevus Zunovo™ as the First and Only Twice-A-Year 10-Minute Subcutaneous Injection for People With Relapsing and Progressive Multiple Sclerosis
| | |

FDA Approves Ocrevus Zunovo™ as the First and Only Twice-A-Year 10-Minute Subcutaneous Injection for People With Relapsing and Progressive Multiple Sclerosis

On Sept. 13, 2024, Genentech announced  that the U.S. Food and Drug Administration (FDA) had approved Ocrevus Zunovo™…